{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:14:47Z","timestamp":1794971687000,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41440-025-02172-5","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:51:21Z","timestamp":1741672281000},"page":"1716-1729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Exploring the high prevalence, comorbidities, and indicators of mild autonomous cortisol secretion in primary aldosteronism: a cohort study and systematic review"],"prefix":"10.1038","volume":"48","author":[{"given":"Chieh","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yuh","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-1522","authenticated-orcid":false,"given":"Chun-Fu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","volume":"39","author":"A Vaidya","year":"2018","unstructured":"Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39:1057\u201388.","journal-title":"Endocr Rev"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/dc07-0525","volume":"30","author":"G Colussi","year":"2007","unstructured":"Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diab care. 2007;30:2349\u201354.","journal-title":"Diab care"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1055\/s-0035-1565208","volume":"47","author":"H Remde","year":"2015","unstructured":"Remde H, Hanslik G, Rayes N, Quinkler M. Glucose metabolism in primary aldosteronism. Horm Metab Res = Horm- und Stoffwechselforschung = Hormones et Metab. 2015;47:987\u201393.","journal-title":"Horm Metab Res = Horm- und Stoffwechselforschung = Hormones et Metab"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diab Endocrinol. 2018;6:41\u201350.","journal-title":"Lancet Diab Endocrinol"},{"key":"2172_CR7","first-page":"1440","volume":"85","author":"R Rossi","year":"2000","unstructured":"Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, et al. Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 2000;85:1440\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189:G1\u2013g42.","journal-title":"Eur J Endocrinol"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","volume":"20","author":"A Prete","year":"2024","unstructured":"Prete A, Bancos I. Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches. Nat Rev Endocrinol. 2024;20:460\u201373.","journal-title":"Nat Rev Endocrinol"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1210\/jc.2010-2743","volume":"96","author":"Y Nakajima","year":"2011","unstructured":"Nakajima Y, Yamada M, Taguchi R, Satoh T, Hashimoto K, Ozawa A, et al. Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab. 2011;96:2512\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR11","first-page":"564","volume":"36","author":"K Fujimoto","year":"2013","unstructured":"Fujimoto K, Honjo S, Tatsuoka H, Hamamoto Y, Kawasaki Y, Matsuoka A, et al. Primary aldosteronism associated with subclinical Cushing syndrome. J Endocrinol Invest. 2013;36:564\u20137.","journal-title":"J Endocrinol Invest"},{"key":"2172_CR12","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1210\/jc.2019-00299","volume":"104","author":"J Gerards","year":"2019","unstructured":"Gerards J, Heinrich DA, Adolf C, Meisinger C, Rathmann W, Sturm L, et al. Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. J Clin Endocrinol Metab. 2019;104:3192\u2013202.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","volume":"58","author":"K Hiraishi","year":"2011","unstructured":"Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, Izumiyama H, et al. Clinicopathological features of primary aldosteronism associated with subclinical Cushing\u2019s syndrome. Endocr J. 2011;58:543\u201351.","journal-title":"Endocr J"},{"key":"2172_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0490-0","volume":"20","author":"S Yasuda","year":"2020","unstructured":"Yasuda S, Hikima Y, Kabeya Y, Iida S, Oikawa Y, Isshiki M, et al. Clinical characterization of patients with primary aldosteronism plus subclinical Cushing\u2019s syndrome. BMC Endocr Disord. 2020;20:9.","journal-title":"BMC Endocr Disord"},{"key":"2172_CR15","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","volume":"76","author":"K-Y Peng","year":"2020","unstructured":"Peng K-Y, Liao H-W, Chan C-K, Lin W-C, Yang S-Y, Tsai Y-C, et al. Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success. Hypertension. 2020;76:1537\u201344.","journal-title":"Hypertension"},{"key":"2172_CR16","doi-asserted-by":"crossref","unstructured":"Hung K, Lee BC, Chen PT, Liu KL, Chang CC, Wu VC, et al. Influence of autonomous cortisol secretion in patients with primary aldosteronism: subtype analysis and postoperative outcome. Endocr Connect. 2023;12:e230121.","DOI":"10.1530\/EC-23-0121"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.2019-00996","volume":"104","author":"DA Heinrich","year":"2019","unstructured":"Heinrich DA, Adolf C, Holler F, Lechner B, Schneider H, Riester A, et al. Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact. J Clin Endocrinol Metab. 2019;104:5658\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jclinepi.2014.05.012","volume":"67","author":"VC Wu","year":"2014","unstructured":"Wu VC, Hu YH, Wu CH, Kao CC, Wang CY, Yang WS, et al. Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan. J Clin Epidemiol. 2014;67:1139\u201349.","journal-title":"J Clin Epidemiol"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","volume":"412","author":"VC Wu","year":"2011","unstructured":"Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, et al. Kidney impairment in primary aldosteronism. Clin Chim Acta. 2011;412:1319\u201325.","journal-title":"Clin Chim Acta"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"key":"2172_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01381-z","volume":"21","author":"TH Barker","year":"2021","unstructured":"Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E, et al. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21:189.","journal-title":"BMC Med Res Methodol"},{"key":"2172_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v049.i05","volume":"49","author":"BC Wallace","year":"2012","unstructured":"Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2012;49:1\u201315.","journal-title":"J Stat Softw"},{"key":"2172_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"2172_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1507\/endocrj.EJ15-0404","volume":"63","author":"Y Tabuchi","year":"2016","unstructured":"Tabuchi Y, Otsuki M, Kasayama S, Kosugi K, Hashimoto K, Yamamoto T, et al. Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan. Endocr J. 2016;63:29\u201335.","journal-title":"Endocr J"},{"key":"2172_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1055\/s-0043-119878","volume":"49","author":"K Inoue","year":"2017","unstructured":"Inoue K, Yamazaki Y, Tsurutani Y, Suematsu S, Sugisawa C, Saito J, et al. Evaluation of cortisol production in aldosterone-producing adenoma. Horm Metab Res. 2017;49:847\u201353.","journal-title":"Horm Metab Res"},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s42000-019-00114-8","volume":"18","author":"PS Bhatt","year":"2019","unstructured":"Bhatt PS, Sam AH, Meeran KM, Salem V. The relevance of cortisol co-secretion from aldosterone-producing adenomas. Hormones. 2019;18:307\u201313.","journal-title":"Hormones"},{"key":"2172_CR28","doi-asserted-by":"publisher","first-page":"E2423","DOI":"10.1210\/clinem\/dgab099","volume":"106","author":"P Gendreitzig","year":"2021","unstructured":"Gendreitzig P, K\u00fcnzel HE, Adolf C, Handgriff L, M\u00fcller L, Holler F, et al. Autonomous cortisol secretion influences psychopathological symptoms in patients with primary aldosteronism. J Clin Endocrinol Metab. 2021;106:E2423\u2013E33.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.steroids.2019.108470","volume":"151","author":"M Kometani","year":"2019","unstructured":"Kometani M, Yoneda T, Demura M, Aono D, Gondoh Y, Karashima S, et al. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia. Steroids. 2019;151:6.","journal-title":"Steroids"},{"key":"2172_CR30","doi-asserted-by":"publisher","first-page":"e3776","DOI":"10.1210\/clinem\/dgaa519","volume":"105","author":"SM O\u2019Toole","year":"2020","unstructured":"O\u2019Toole SM, Sze W-CC, Chung T-T, Akker SA, Druce MR, Waterhouse M, et al. Low-grade cortisol cosecretion has limited impact on ACTH-stimulated AVS parameters in primary aldosteronism. J Clin Endocrinol Metab. 2020;105:e3776\u2013e84.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR31","doi-asserted-by":"crossref","unstructured":"Araujo-Castro M, Paja Fano M, Pla Peris B, Gonz\u00e1lez Boillos M, Pascual-Corrales E, Garc\u00eda-Cano AM, et al. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes. Endocr Connect. 2023;12:e230043.","DOI":"10.1530\/EC-23-0043"},{"key":"2172_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-21-1131","volume":"186","author":"T Katabami","year":"2022","unstructured":"Katabami T, Matsuba R, Kobayashi H, Nakagawa T, Kurihara I, Ichijo T, et al. Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk. Eur J Endocrinol. 2022;186:645\u201355.","journal-title":"Eur J Endocrinol"},{"key":"2172_CR33","doi-asserted-by":"publisher","unstructured":"Q-Q Plot (Quantile to Quantile Plot). In: The Concise Encyclopedia of Statistics.https:\/\/doi.org\/10.1007\/978-0-387-32833-1_331) Springer New York: New York, NY, 2008, 437-9.","DOI":"10.1007\/978-0-387-32833-1_331)"},{"key":"2172_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith Davey, Schneider G, Minder M. C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"2172_CR35","doi-asserted-by":"crossref","unstructured":"Olsen H, Olsen M. Associations of age, BMI, and renal function to cortisol after dexamethasone suppression in patients with adrenal incidentalomas. Front Endocrinol. 2023;13:1055298.","DOI":"10.3389\/fendo.2022.1055298"},{"key":"2172_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000443435","volume":"41","author":"X Li","year":"2016","unstructured":"Li X, Xiang X, Hu J, Goswami R, Yang S, Zhang A, et al. Association between serum cortisol and chronic kidney disease in patients with essential hypertension. Kidney Blood Press Res. 2016;41:384\u201391.","journal-title":"Kidney Blood Press Res"},{"key":"2172_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41440-023-01400-0","volume":"47","author":"CF Lai","year":"2024","unstructured":"Lai CF, Lin YH, Huang KH, Chueh JS, Wu VC. Kidney function predicts new-onset cardiorenal events and mortality in primary aldosteronism: approach of the 2021 race-free eGFR equation. Hypertens Res. 2024;47:233\u201344.","journal-title":"Hypertens Res"},{"key":"2172_CR38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7326\/M20-7946","volume":"174","author":"A Kjellbom","year":"2021","unstructured":"Kjellbom A, Lindgren O, Puvaneswaralingam S, L\u00f6ndahl M, Olsen H. Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas : a cohort study. Ann Intern Med. 2021;174:1041\u20139.","journal-title":"Ann Intern Med"},{"key":"2172_CR39","doi-asserted-by":"publisher","first-page":"e3307","DOI":"10.1210\/clinem\/dgaa410","volume":"105","author":"S Singh","year":"2020","unstructured":"Singh S, Atkinson EJ, Achenbach SJ, LeBrasseur N, Bancos I. Frailty in patients with mild autonomous cortisol secretion is higher than in patients with nonfunctioning adrenal tumors. J Clin Endocrinol Metab. 2020;105:e3307\u2013e15.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR40","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1210\/jc.2006-0736","volume":"91","author":"C Catena","year":"2006","unstructured":"Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, et al. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab. 2006;91:3457\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab. 2006;91:454\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41440-022-01086-w","volume":"46","author":"VC Wu","year":"2023","unstructured":"Wu VC, Chan CK, Wu WC, Peng KY, Chang YS, Yeh FY, et al. New-onset diabetes mellitus risk associated with concurrent autonomous cortisol secretion in patients with primary aldosteronism. Hypertension Res. 2023;46:445\u201355.","journal-title":"Hypertension Res"},{"key":"2172_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41440-022-01149-y","volume":"46","author":"K Yokota","year":"2023","unstructured":"Yokota K, Sone M. Autonomous cortisol secretion in patients with primary aldosteronism: a possible risk factor for new-onset diabetes mellitus. Hypertens Res. 2023;46:803\u20135.","journal-title":"Hypertens Res"},{"key":"2172_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1369582","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Zhou L, Zhang C, Su T, Jiang L, Zhou W, et al. The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism. Front Endocrinol (Lausanne). 2024;15:1369582.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2172_CR45","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1210\/jc.2001-011766","volume":"87","author":"L Tauchmanov\u00e0","year":"2002","unstructured":"Tauchmanov\u00e0 L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, et al. Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab. 2002;87:4872\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR46","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1210\/jc.2018-00617","volume":"103","author":"C Adolf","year":"2018","unstructured":"Adolf C, K\u00f6hler A, Franke A, Lang K, Riester A, L\u00f6w A, et al. Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy. J Clin Endocrinol Metab. 2018;103:4543\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR47","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/HYPERTENSIONAHA.122.19472","volume":"79","author":"G Brosolo","year":"2022","unstructured":"Brosolo G, Catena C, Da Porto A, Bulfone L, Vacca A, Verheyen ND, et al. Differences in regulation of cortisol secretion contribute to left ventricular abnormalities in patients with essential hypertension. Hypertension (Dallas, Tex : 1979). 2022;79:1435\u201344.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"2172_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/EJE-21-1157","volume":"187","author":"CH Tsai","year":"2022","unstructured":"Tsai CH, Liao CW, Wu XM, Chen ZW, Pan CT, Chang YY, et al. Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data. Eur J Endocrinol. 2022;187:197\u2013208.","journal-title":"Eur J Endocrinol"},{"key":"2172_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41440-024-01935-w","volume":"48","author":"B-C Lee","year":"2025","unstructured":"Lee B-C, Chang C-C, Kang VJ-W, Huang J-Z, Lin Y-L, Chang Y-Y, et al. Autonomous cortisol secretion promotes vascular calcification in vivo and in vitro under hyperaldosteronism. Hypertens Res. 2025;48:366\u201377.","journal-title":"Hypertens Res"},{"key":"2172_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/cen.14651","volume":"96","author":"J Bleier","year":"2022","unstructured":"Bleier J, Pickovsky J, Apter S, Fishman B, Dotan Z, Tirosh A, et al. The association between adrenal adenoma size, autonomous cortisol secretion and metabolic derangements. Clin Endocrinol. 2022;96:311\u20138.","journal-title":"Clin Endocrinol"},{"key":"2172_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-22-0286","volume":"187","author":"WC Wu","year":"2022","unstructured":"Wu WC, Peng KY, Lu JY, Chan CK, Wang CY, Tseng FY, et al. Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics. Eur J Endocrinol. 2022;187:519\u201330.","journal-title":"Eur J Endocrinol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02172-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:03:54Z","timestamp":1748927034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02172-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02172-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}